Phio Pharmaceuticals Corp.
PHIO
$1.09
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 13.00M | 17.03M | 21.03M | 10.71M | 10.78M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.30M | 371.00K | 445.00K | 788.00K | 519.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 14.30M | 17.40M | 21.48M | 11.49M | 11.29M |
|
|
|||||
| Total Current Assets | 14.30M | 17.40M | 21.48M | 11.49M | 11.29M |
| Net Property, Plant & Equipment | 9.00K | 10.00K | 11.00K | 12.00K | 7.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 14.31M | 17.41M | 21.49M | 11.51M | 11.30M |
|
|
|||||
| Total Accounts Payable | 901.00K | 260.00K | 435.00K | 516.00K | 235.00K |
| Total Accrued Expenses | 804.00K | 690.00K | 905.00K | 1.15M | 971.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.71M | 950.00K | 1.34M | 1.67M | 1.21M |
|
|
|||||
| Total Current Liabilities | 1.71M | 950.00K | 1.34M | 1.67M | 1.21M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.71M | 950.00K | 1.34M | 1.67M | 1.21M |
|
|
|||||
| Common Stock & APIC | 175.80M | 175.52M | 175.20M | 162.52M | 160.39M |
| Retained Earnings | -163.20M | -159.06M | -155.05M | -152.68M | -150.29M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 12.60M | 16.46M | 20.15M | 9.84M | 10.10M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 12.60M | 16.46M | 20.15M | 9.84M | 10.10M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 12.60M | 16.46M | 20.15M | 9.84M | 10.10M |
|
|
|||||